Adoption of Prefillable Syringes Rising, Especially In High-cost Drug Applications to Contain Wastage, Notes Frost & Sullivan

Adoption of Prefillable Syringes Rising, Especially In High-cost Drug Applications to Contain Wastage, Notes Frost & Sullivan PR Newswire LONDON, July 25, 2012 - Growing demand for safety features, coupled with growing market for self-injection is fuelling demand for PFS LONDON, July 25, 2012 /PRNewswire/ -- The prefillable syringes (PFS) market in Europe is growing due to the convenience, efficiency, and safety PFS offers. There is an increasing use of PFS in high-cost drug applications as well, in order to contain wastage. Most of the Europe-based PFS manufacturers have either expanded their capacity or are planning further capacity expansion in the next two or three years. For now, the market is dominated by Becton, Dickinson and Company (BD), which accounts for a market share of approximately 70 per cent. New analysis from Frost & Sullivan (http://www.pharma.frost.com), Analysis of the European Prefillable Syringes Market, finds that the total European demand for glass prefillable syringes for all therapeutic applications combined was roughly 1.63 billion units in 2011. The demand for PFS is expected to grow to approximately 3.62 billion units by 2018 in Europe at a CAGR of 10.3 per cent.